Wolfe Research downgraded Matson (MATX) to Peer Perform from Outperform. The firm cites valuation for the downgrade. Matson has materially ...

Wolfe Research started coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a report published on Friday, MarketBeat reports. The brokerage issued a peer perform rating on the medical research ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of BioMarin Pharmaceutical (NasdaqGS:BMRN) with a ...

QLSTM, a hybrid quantum-classical model, excels at stock price prediction, achieving a 50 % reduction in RMSE and a 10% ...

Wolfe Research analyst Doug Schenkel initiated coverage of Repligen (RGEN) with a Peer Perform rating and no price target Bioprocessing tools ...

Wolfe Research upgrades Warner Bros. Discovery to peer perform, citing potential for stable EBITDA and debt reduction through ...

The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on desktop, mobile, and our app for subscribers only. To enjoy the e-Newspaper ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management ...

On Monday, Wolfe Research adjusted its stance on shares of Danaher Corporation (NYSE:DHR), upgrading the stock from Peerperform to Outperform and setting a new price target of $285.00. The research ...

On Monday, Wolfe Research adjusted its stance on shares of Danaher Corporation (NYSE:DHR), upgrading the stock from Peerperform to Outperform and setting a new price target of $285.00. The ...